1. de Thé, G and Bomford, R. (1993) An HTLV-1 vaccine: why, how, for whom? AIDS Res Hum Retroviruses, 9, pp. 381 - 386. [CSA]
2. Haas, B and Bergstrom, E and Jamous, A and Bennie, A. (1996) The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury Spinal Cord, 34, pp. 560 - 564. [INFOTRIEVE][CSA]
3. Kaplan, J and Osame, M and Kubota, H and Igata, A and Nishitani, H and Maeda, Y and Khabbaz, R and Janssen, R. (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-1 J Acquir Immune Defic Syndr, 3, pp. 1096 - 1101. [INFOTRIEVE][CSA]
4. Roman, G and Roman, L. (1988) Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome J Neurol Sci, 87, pp. 121 - 138. [INFOTRIEVE][CROSSREF][CSA]
5. Vernant, J and Maurs, L and Gessain, A and Barin, F and Gout, O and Delaporte, J and Sanhadji, K and Buisson, G and de Thé, G. (1987) Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type 1: a clinical and seroepidemiological study of 25 cases Ann Neurol, 21, pp. 123 - 130. [INFOTRIEVE][CROSSREF][CSA]